Molecules with neurotrophic effects on the human developing mesencephalic dopaminergic neurons

Area of Science:

• Neuroscience
• Developmental Biology
• Neurodegenerative Diseases

Background:

• Parkinson's disease (PD) involves the loss of dopamine-producing neurons in the brain.
• Identifying factors that protect these neurons is crucial for PD treatment.
• The early development of these neurons in the human brain is not fully understood.

Purpose of the Study:

• To characterize the origin and development of mesencephalic dopaminergic (mesDA) neurons in the human embryo.
• To investigate the effects of neurotrophic factors on the survival and function of these neurons in vitro.
• To explore potential therapeutic targets for Parkinson's disease.

Main Methods:

• Human fetal mesencephalon tissue was analyzed from 5.0 to 12 Postconception (PC) weeks.
• Tyrosine Hydroxylase (TH) immunoreactivity was used to identify dopaminergic neurons.
• Primary neuronal cultures were treated with basic Fibroblast Growth Factor (bFGF) and Nerve Growth Factor (NGF).

Main Results:

• TH-immunoreactive cells were first observed at 5.5 PC weeks.
• In vitro, bFGF significantly increased both the number of TH-immunoreactive neurons and their enzymatic activity.
• bFGF's effects were mediated by glial fibrillary acidic protein-immunoreactive cells, while NGF had no significant impact.

Conclusions:

• bFGF demonstrates a potential role in promoting the survival and function of human mesDA neurons.
• These findings suggest bFGF could be a therapeutic candidate for Parkinson's disease.
• Further in vivo studies are warranted to confirm these preliminary results and explore clinical applications.